Cargando…

Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models

Nucleotide-binding oligomerization domain NOD-like receptors (NLRs) are conserved cytosolic pattern recognition receptors (PRRs) that track the intracellular milieu for the existence of infection, disease-causing microbes, as well as metabolic distresses. The NLRP3 inflammasome agglomerates are cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Biswadeep, Sarkar, Chayna, Rawat, Vikram Singh, Kalita, Deepjyoti, Deka, Sangeeta, Agnihotri, Akash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399941/ https://www.ncbi.nlm.nih.gov/pubmed/34443594 http://dx.doi.org/10.3390/molecules26164996

Ejemplares similares

Leading 20 drug–drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients
por: Das, Biswadeep, et al.
Publicado: (2021)

Effectiveness of Sample Pooling Strategies for SARS-CoV-2 Mass Screening by RT-PCR: A Scoping Review
por: Deka, Sangeeta, et al.
Publicado: (2020)

Circulation of an atypical hepatitis C virus (HCV) strain at a dialysis unit in northeast India
por: Kalita, Deepjyoti, et al.
Publicado: (2020)

Prevalence and Risk Factors of Intestinal Parasitic Infection in Under-Five Children With Malnutrition: A Hospital Based Cross-Sectional Study
por: Deka, Sangeeta, et al.
Publicado: (2022)

Heavy Load of Intestinal Fluke in a Four-Year-Old Child with Severe Acute Malnutrition: A Case Report
por: Deka, Sangeeta, et al.
Publicado: (2022)

Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development
por: Sarkar, Chayna, et al.
Publicado: (2023)

High Prevalence of Antibiotic-Resistant Gram-Negative Bacteria Causing Surgical Site Infection in a Tertiary Care Hospital of Northeast India
por: Deka, Sangeeta, et al.
Publicado: (2020)

Analysis of Multi-Sample Pools in the Detection of SARS-CoV-2 RNA for Mass Screening: An Indian Perspective
por: Deka, Sangeeta, et al.
Publicado: (2020)

The intricate association of COVID-19 pandemic with ecological issues
por: Deka, Sangeeta, et al.
Publicado: (2022)

A contemporary insight into the sero-epidemiology of Toxoplasma gondii infection in the foot-hills of Himalayas: A cross-sectional study from a tertiary care center in Northern India
por: Deka, Sangeeta, et al.
Publicado: (2021)

Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
por: Zhang, Xiaolu, et al.
Publicado: (2023)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

Increased Isolation of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli From Community-Onset Urinary Tract Infection Cases in Uttarakhand, India
por: Kumar, Nitin, et al.
Publicado: (2021)

Simultaneous infection of Hepatitis A and Hepatitis E viruses amongst acute viral hepatitis patients: A hospital-based study from Uttarakhand
por: Kalita, Deepjyoti, et al.
Publicado: (2020)

High proportion of drug-resistant isolates in adult community-acquired pneumonia from Northeast India: A hospital-based study
por: Kalita, Deepjyoti, et al.
Publicado: (2021)

A Comparative Evaluation of Antigen-Specific Sandwich Immunoassay and Indirect Immunofluorescence Assay (IIF) in Detecting Antineutrophil Cytoplasmic Antibodies: Are We Ready to Replace IIF with ELISA as the Primary Screening Method?
por: Deka, Sangeeta, et al.
Publicado: (2021)

Seroprevalence and Determinants of ToRCH Pathogens in Pregnant Women in the Sub-Himalayan Region
por: Deka, Sangeeta, et al.
Publicado: (2022)

Boron-Based Inhibitors of the NLRP3 Inflammasome
por: Baldwin, Alex G., et al.
Publicado: (2017)

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
por: Mezzaroma, Eleonora, et al.
Publicado: (2021)

Enamel Surface Damage following Debonding of Ceramic Brackets: A Hospital-Based Study
por: Bora, Neelutpal, et al.
Publicado: (2021)

Indian Medical Undergraduates’ Perceptions of Effective Teaching Methods: A Cross-Sectional Study
por: Mahanta, Putul, et al.
Publicado: (2021)

Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
por: Thapa, Pritam, et al.
Publicado: (2023)

NLRP3 inflammasome and its inhibitors: a review
por: Shao, Bo-Zong, et al.
Publicado: (2015)

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
por: Nizami, Sohaib, et al.
Publicado: (2020)

NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity
por: Wei, Shanshan, et al.
Publicado: (2021)

Identification of ethyl pyruvate as a NLRP3 inflammasome inhibitor that preserves mitochondrial integrity
por: Li, Sujun, et al.
Publicado: (2018)

Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
por: Das, Biswadeep, et al.
Publicado: (2020)

The NLRP3 Inflammasome Inhibitor Dapansutrile Attenuates Cyclophosphamide-Induced Interstitial Cystitis
por: Kiran, Sonia, et al.
Publicado: (2022)

Design, Synthesis and Evaluation of Oxazaborine Inhibitors of the NLRP3 Inflammasome
por: Baldwin, Alex G., et al.
Publicado: (2018)

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
por: Zhan, Xiaoyan, et al.
Publicado: (2023)

Assessing the knowledge of medical undergraduates on oral anticoagulation therapy
por: Sarkar, Chayna, et al.
Publicado: (2023)

Evaluation of Time Consumption for Debonding Brackets Using Different Techniques: A Hospital-Based Study
por: Bora, Neelutpal, et al.
Publicado: (2021)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

NLRP3 Inflammasome Activation by Paracoccidioides brasiliensis
por: Tavares, Aldo Henrique, et al.
Publicado: (2013)

A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases
por: Docherty, Callum AH, et al.
Publicado: (2023)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
por: Yang, Yang, et al.
Publicado: (2019)

Design, synthesis, and screening of sulfonylurea-derived NLRP3 inflammasome inhibitors
por: Kulkarni, Amol A., et al.
Publicado: (2019)

Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor
por: Agarwal, Sameer, et al.
Publicado: (2020)

Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nmruq8qq5ljhc11jk4h191gjmh